Based on this idea, Rhodes et al. [18] proposed to identify conditional regulatory programs by defining gene expression signatures (differentially expressed genes between cancer and normal samples) and putative TF regulatory signatures (a set of genes containing binding sites of a TF) and examining their overlap. Here, TF is linked to cancer.